Dr. Tanya Stoyanova discusses new paper “UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas” with Andrea Miyahira of PCF


Andrea Miyahira hosts Tanya Stoyanova to discuss her study, published in Cell Reports Medicine, on UCHL1 as a potential biomarker and therapeutic target for neuroendocrine carcinomas, including neuroendocrine prostate cancer. Watch below or at the link.
Link to Video with Transcript: https://www.urotoday.com/video-lectures/prostate-cancer/video/4083-uchl1-a-potential-biomarker-and-therapeutic-target-for-neuroendocrine-prostate-cancer-tanya-stoyanova.html